Micropulse diode laser photocoagulation for central serous chorio-retinopathy

Clin Exp Ophthalmol. 2009 Nov;37(8):801-5. doi: 10.1111/j.1442-9071.2009.02157.x.

Abstract

Purpose: Central serous chorioretinopathy (CSC) is usually characterized by a localized detachment of the neurosensory retina that is self-limiting. However, some cases may persist or recur leading to degenerative changes of the retinal pigment epithelium and the neurosensory retina resulting in severe visual loss and requiring intervention.

Methods: This retrospective case series reports the long-term visual outcome of the use of micropulse laser photocoagulation for this condition with a review of literature.

Results: The mean follow up was 17.1 months. Four of the five patients had complete resolution of symptoms whereas one patient had recurrent CSC from a new leak that failed to resolve after repeat micropulse treatment despite improvement in symptoms.

Discussion: The outcomes in this case series confirm the long-term efficacy of micropulse laser in the management of CSC. It produces therapeutic effects that appear comparable to those of conventional photocoagulation with no detectable signs of laser-induced iatrogenic damage.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Central Serous Chorioretinopathy / radiotherapy*
  • Follow-Up Studies
  • Humans
  • Lasers, Semiconductor*
  • Light Coagulation / instrumentation*
  • Low-Level Light Therapy / instrumentation*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Visual Acuity